Skip to search formSkip to main contentSkip to account menu

Topical Suspension

Known as: Topical Suspension [Dose Form], Top Susp, Topical Suspension Dosage Form 
A suspension intended for administration to a body surface.
National Institutes of Health

Related topics

Related topics

1 relation
BCG, Live, Tice Strain 50 MG/ML Topical Suspension [Tice BCG]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
A Preliminary, Open Label, Single-arm Study of Calcipotriene/Betamethasone Topical Suspension as a Supplement to Non-biologic Systemic Therapy for Psoriasis.
BACKGROUND Calcipotriene/betamethasone topical suspension is a topical therapy that is often used as monotherapy as a first-line… 
2016
2016
More rapid improvement in quality of life with fixed-combination calcipotriene plus betamethasone dipropionate aerosol foam vs. topical suspension (PSO-ABLE study in patients with psoriasis vulgaris)
2015
2015
An Applicator Delivery System for Fixed-Combination Calcipotriene Plus Betamethasone Dipropionate Topical Suspension (Gel): Innovating Psoriasis Vulgaris Treatment Through Patient Collaboration
AbstractTreatment non-adherence is a complex problem encountered in all therapy areas, particularly in chronic diseases such as… 
2014
2014
Real-life treatment profile of calcipotriene and betamethasone dipropionate topical suspension in patients with psoriasis vulgaris.
BACKGROUND Treatment with calcipotriene plus betamethasone dipropionate (CBD) fixed-combination topical suspension has been shown… 
2014
2014
Calcipotriene 0.005%--betamethasone dipropionate 0.064% ointment versus topical suspension in the treatment of plaque psoriasis: a randomized pilot study of patient preference.
Vehicle formulation plays a major role in patient adherence to topical psoriasis treatments. The objective of this study was to… 
2011
2011
Natroba (spinosad) 0.9% suspension topical suspension for head lice.
Review
2011
Review
2011
Spinosad (Natroba) topical suspension for head lice.
The FDA has approved spinosad 0.9% suspension(Natroba – ParaPro) for topical treatment of head liceinfestation in patients >4… 
2011
2011
Calcipotriene 0.005% and betamethasone dipropionate 0.064% combination topical suspension (Taclonex Scalp).
2002
2002
Morphological evidence of M cells in healthy canine conjunctiva-associated lymphoid tissue
Abstract.Purpose: To characterize the follicle-associated epithelium (FAE) and organized lymphoid nodules from dog nictitating… 
2002
2002
Development of a Topical Suspension Containing Three Active Ingredients
ABSTRACT The objective of this study was to develop a topical suspension that contains sarafloxacin hydrochloride (1 mg/mL… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)